<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> AP900503-0015 </DOCNO><FILEID>AP-NR-05-03-90 0200EDT</FILEID><FIRST>r a PM-BoneLoss     05-03 0209</FIRST><SECOND>PM-Bone Loss,0216</SECOND><HEAD>Drug Prevents Vertebral Fractures in Elderly Women</HEAD><DATELINE>BOSTON (AP) </DATELINE><TEXT>   A drug can stop and even reverse the loss of bonein the spine and prevent fractures in older women withosteoporosis, a common condition in which the bones become brittle,according to a study today.   Danish doctors tested the medicine, called etidronate.   Between 15 million and 20 million Americans are estimated tohave osteoporosis.   The condition is blamed for 1.3 million fractures annually inpeople over age 45. It is especially common among older women, whodevelop osteoporosis after menopause when their bodies make lessestrogen.   The research, directed by Dr. Tommy Storm at Sundby Hospital inCopenhagen, was published in the New England Journal of Medicine.It was financed by Procter andamp; Gamble's Norwich EatonPharmaceuticals, which makes etidronate.   The doctors performed a three-year comparison study on 66 women,ages 56 to 75. They found that the vertebral bone mineral contentof those who got the drug increased 7 percent, while it decreased 3percent in a comparison group who got dummy pills.   The number of vertebral fractures also decreased substantiallyin the etidronate group.   The medicine is approved by the Food and Drug Administration fortreatment of Paget's disease, a bone ailment.</TEXT></DOC>